Ptc Drug Patent Portfolio

Ptc owns 1 orange book drug protected by 4 US patents Given below is the list of Ptc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12257252 Compositions And Methods For Increasing Tetrahydrobiopterin Plasma Exposure 06 Mar, 2042
Active
US11752154 Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof 04 Sep, 2038
Active
US12213982 Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof 04 Sep, 2038
Active
US11072614 Polymorphs Of Sepiapterin And Salts Thereof 16 Apr, 2038
Active


Given below is the list of recent legal activities going on the following drug patents of Ptc.

Activity Date Patent Number
Patent litigations
Email Notification 17 Sep, 2025 US12257252
Patent eCofC Notification 16 Sep, 2025 US12257252
Recordation of Patent eCertificate of Correction 16 Sep, 2025 US12257252
Mail Patent eCofC Notification 16 Sep, 2025 US12257252
Post Issue Communication - Certificate of Correction 21 Aug, 2025 US12257252
Email Notification 27 May, 2025 US12213982
Mail O.P. Petition Decision 27 May, 2025 US12213982
Mail-Petition Decision - Dismissed 23 May, 2025 US12213982
Petition Decision - Dismissed 22 May, 2025 US12213982
O.P. Petition Decision 21 May, 2025 US12213982
RX - Mail Miscellaneous Communication to Applicant 16 May, 2025 US12213982
Information Disclosure Statement considered 15 May, 2025 US12213982
Patent eGrant Notification 25 Mar, 2025 US12257252
Email Notification 25 Mar, 2025 US12257252
Mail Patent eGrant Notification 25 Mar, 2025 US12257252


Ptc's Family Patents


Family Patents



Ptc Drug List

Given below is the complete list of Ptc's drugs and the patents protecting them.


1. Sephience

Sephience is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12257252 Compositions And Methods For Increasing Tetrahydrobiopterin Plasma Exposure 06 Mar, 2042
(15 years from now)
Active
US11752154 Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof 04 Sep, 2038
(12 years from now)
Active
US12213982 Pharmaceutical Compositions Comprising Sepiapterin And Uses Thereof 04 Sep, 2038
(12 years from now)
Active
US11072614 Polymorphs Of Sepiapterin And Salts Thereof 16 Apr, 2038
(12 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sephience's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List